Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Research Article

Sialuria-Related Intellectual Disability in Children and Adolescent of Pakistan: Tenth Patient Described has a Novel Mutation in the GNE Gene

Author(s): Hina Ishtiaq, Sonia Siddiqui*, Rukhsana Nawaz, Khawar Saeed Jamali and Abdul Ghani Khan

Volume 19 , Issue 2 , 2020

Page: [127 - 141] Pages: 15

DOI: 10.2174/1871527319666200213115747

Price: $65

Abstract

Background: Sialuria is a rare inborn error of metabolism caused by excessive synthesis of sialic acid due to the mutation in the binding site of the cytidine monophosphate-sialic acid of UDPGlcNAc 2-Epimerase/ManNAc Kinase (GNE/MNK).

Objective: This is the first study investigating the molecular basis of neuronal disorders exhibiting sialuria in Pakistani children/adolescents.

Methods: The current study genotyped GNE SNPs rs121908621, rs121908622 and rs121908623 by using PCR, RFLP, and DNA sequencing methods. Socioeconomic and clinical histories were also recorded.

Results: Our data suggest that clinical symptoms and financial status play a significant role in conferring sialuria related Intellectual Disability (ID). SNP: rs121908623 showed G/A substitution (R263Q) in the GNE gene.

Conclusion: We have identified one case study in Pakistan, so this makes our research a leap forward towards the identification of the 10th case study worldwide.

Keywords: Sialuria, intellectual disability, single nucleotide polymorphism, arginine (R), glutamine (Q), metabolic error.

Graphical Abstract
[1]
Klootwijk RD, Savelkoul PJ, Ciccone C, et al. Allele-specific silencing of the dominant disease allele in sialuria by RNA interference. FASEB J 2008; 22(11): 3846-52.
[http://dx.doi.org/10.1096/fj.08-110890] [PMID: 18653764]
[2]
Leroy JG, Seppala R, Huizing M, et al. Dominant inheritance of sialuria, an inborn error of feedback inhibition. Am J Hum Genet 2001; 68(6): 1419-27.
[http://dx.doi.org/10.1086/320598] [PMID: 11326336]
[3]
Rajendiran KS, Ananthanarayanan RH, Satheesh S, Rajappa M. Elevated levels of serum sialic acid and high-sensitivity C-reactive protein: markers of systemic inflammation in patients with chronic heart failure. Br J Biomed Sci 2014; 71(1): 29-32.
[http://dx.doi.org/10.1080/09674845.2014.11669959] [PMID: 24693572]
[4]
Crook M, Cartwright K, Lumb P, Worsley A. Serum sialic acid in young type-1 diabetic patients. Diabetes Res Clin Pract 2000; 47(2): 119-22.
[http://dx.doi.org/10.1016/S0168-8227(99)00121-7] [PMID: 10670911]
[5]
Gruszewska E, Cylwik B, Panasiuk A, Szmitkowski M, Flisiak R, Chrostek L. Total and free serum sialic acid concentration in liver diseases. BioMed Res Int 2014; 2014876096
[http://dx.doi.org/10.1155/2014/876096] [PMID: 24959592]
[6]
Fontaine G, Biserte G, Montreuil J, Dupont A, Farriaux JP. La sialurie: un trouble métabolique original? Helv Paediatr Acta, Suppl 1968; 17: 1-32.
[7]
Wilcken B, Don N, Greenaway R, Hammond J, Sosula L. Sialuria: a second case. J Inherit Metab Dis 1987; 10(2): 97-102.
[http://dx.doi.org/10.1007/BF01800030] [PMID: 2443758]
[8]
Seppala R, Lehto VP, Gahl WA. Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. Am J Hum Genet 1999; 64(6): 1563-9.
[http://dx.doi.org/10.1086/302411] [PMID: 10330343]
[9]
Krasnewich DM, Tietze F, Krause W, et al. Clinical and biochemical studies in an American child with sialuria. Biochem Med Metab Biol 1993; 49(1): 90-6.
[http://dx.doi.org/10.1006/bmmb.1993.1010] [PMID: 8439453]
[10]
Ferreira H, Seppala R, Pinto R, et al. Sialuria in a Portuguese girl: clinical, biochemical, and molecular characteristics. Mol Genet Metab 1999; 67(2): 131-7.
[http://dx.doi.org/10.1006/mgme.1999.2852] [PMID: 10356312]
[11]
Leroy JG, Dacremont G, Desimpel H, Van Coster R. Sialuria (French type): new observation of this rare disorder. Am J Hum Genet 1998; 63: A269.
[12]
Champaigne NL, Leroy JG, Kishnani PS, et al. New observation of sialuria prompts detection of liver tumor in previously reported patient. Mol Genet Metab 2016; 118(2): 92-9.
[http://dx.doi.org/10.1016/j.ymgme.2016.04.004]
[13]
Hinds DA, Stuve LL, Nilsen GB, et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005; 307(5712): 1072-9.
[http://dx.doi.org/10.1126/science.1105436] [PMID: 15718463]
[14]
Rivera NV, Carreras-Torres R, Roncarati R, et al. Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. BMC Med Genet 2013; 14(1): 11.
[http://dx.doi.org/10.1186/1471-2350-14-11] [PMID: 23343465]
[15]
He F, Teng X, Gu H, et al. Interleukin-6 receptor rs7529229 T/C polymorphism is associated with left main coronary artery disease phenotype in a Chinese population. Int J Mol Sci 2014; 15(4): 5623-33.
[http://dx.doi.org/10.3390/ijms15045623] [PMID: 24699044]
[16]
Martinez NN, Lipke M, Robinson J, Wilcken B. Sialuria: ninth patient described has a novel mutation in GNE. JIMD Rep 2019; 44(44): 17-21.
[PMID: 29923088]
[17]
Wasay M, Khatri IA. Neurology in Pakistan: growing burden, low on priority, and a hope to keep alive. Neurology 2013; 80(6): 581-2.
[http://dx.doi.org/10.1212/WNL.0b013e3182815403] [PMID: 23382368]
[18]
Singh V, Tiwari RL, Dikshit M, Barthwal MK. Models to study atherosclerosis: a mechanistic insight. Curr Vasc Pharmacol 2009; 7(1): 75-109.
[http://dx.doi.org/10.2174/157016109787354097] [PMID: 19149643]
[19]
Picher-Martel V, Dupre N. Current and promising therapies in autosomal recessive ataxias. CNS Neurol Disord Drug Targets 2018; 17(3): 161-71.
[http://dx.doi.org/10.2174/1871527317666180419115029]
[20]
Feng Y, Zhang S, Zhang Z, et al. Understanding genotypes and phenotypes of the mutations in voltage-gated sodium channel α subunits in epilepsy. CNS Neurol Disord Drug Targets 2019; 18(4): 266-72.
[http://dx.doi.org/10.2174/1871527317666181026164825] [PMID: 30370865]
[21]
Froehlich-Santino W, Londono Tobon A, Cleveland S, et al. Prenatal and perinatal risk factors in a twin study of autism spectrum disorders. J Psychiatr Res 2014; 54: 100-8.
[http://dx.doi.org/10.1016/j.jpsychires.2014.03.019] [PMID: 24726638]
[22]
Zheng X, Chen R, Li N, et al. Socioeconomic status and children with intellectual disability in China. J Intellect Disabil Res 2012; 56(2): 212-20.
[http://dx.doi.org/10.1111/j.1365-2788.2011.01470.x] [PMID: 21917049]
[23]
Patel V, Araya R, de Lima M, Ludermir A, Todd C. Women, poverty and common mental disorders in four restructuring societies. Soc Sci Med 1999; 49(11): 1461-71.
[http://dx.doi.org/10.1016/S0277-9536(99)00208-7] [PMID: 10515629]
[24]
Bhatti A, Ashfaq G. Frequency of chromosomal anomalies in mentally handicapped children. Pak J Med Res 2008; 47(1): 47-59.
[25]
Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium of Psychiatric Epidemiology. Bull World Health Organ 2000; 78(4): 413-26.
[26]
Yang H, Yang Y, Qu S, et al. Growth factor changes in crebrospinal fluid of children with mental retardation before and after neural precursor cell transplantation. CNS Neurol Disord Drug Targets 2018; 17(2): 98-105.
[http://dx.doi.org/10.2174/1871527317666180411102337] [PMID: 29637872]
[27]
Ormstad H, Bryn V, Verkerk R, et al. Serum tryptophan, tryptophan catabolites and brain-derived neurotrophic factor in subgroups of youngsters with autism spectrum disorders. CNS Neurol Disord Drug Targets 2018; 17(8): 626-39.
[http://dx.doi.org/10.2174/1871527317666180720163221] [PMID: 30033880]
[28]
Tyner E, Oropeza M, Figueroa J, Peña ICD. Childhood hypertension and effects on cognitive functions: mechanisms and future perspectives. CNS Neurol Disord Drug Targets 2019; 18(9): 677-86.
[http://dx.doi.org/10.2174/1871527318666191017155442] [PMID: 31749437]
[29]
Seyedi M, Gholami F, Samadi M, et al. The effect of vitamin D3 supplementation on serum BDNF, dopamine, and serotonin in children with attention-deficit/hyperactivity disorder. CNS Neurol Disord Drug Targets 2019; 18(6): 496-501.
[http://dx.doi.org/10.2174/1871527318666190703103709] [PMID: 31269890]
[30]
El Fotoh WMMA, El Naby SAA, Abd El Hady NMS. Autism spectrum disorders: the association with inherited metabolic disorders and some trace elements. A retrospective study. CNS Neurol Disord Drug Targets 2019; 18(5): 413-20.
[PMID: 31208314]
[31]
de Celis-Alonso B, Hidalgo-Tobón SS, Barragán-Pérez E, et al. Different food odors control brain connectivity in impulsive children. CNS Neurol Disord Drug Targets 2019; 18(1): 63-77.
[http://dx.doi.org/10.2174/1871527317666181105105113] [PMID: 30394220]
[32]
Seppala R, Tietze F, Krasnewich D, et al. Sialic acid metabolism in sialuria fibroblasts. J Biol Chem 1991; 266(12): 7456-61.
[PMID: 2019577]
[33]
Weiss P, Tietze F, Gahl WA, Seppala R, Ashwell G. Identification of the metabolic defect in sialuria. J Biol Chem 1989; 264(30): 17635-6.
[PMID: 2808337]
[34]
Don NA, Wilcken B. Sialuria: a follow-up report. J Inherit Metab Dis 1991; 14(6): 942.
[http://dx.doi.org/10.1007/BF01800480] [PMID: 1779656]
[35]
Gahl MJ, Finke MD, Crenshaw TD, Benevenga NJ. Efficiency of lysine or threonine retention in growing rats fed diets limiting in either lysine or threonine. J Nutr 1996; 126(12): 3090-9.
[http://dx.doi.org/10.1093/jn/126.12.3090] [PMID: 9001379]
[36]
Yarema KJ, Goon S, Bertozzi CR. Metabolic selection of glycosylation defects in human cells. Nat Biotechnol 2001; 19(6): 553-8.
[http://dx.doi.org/10.1038/89305] [PMID: 11385460]
[37]
Penner J, Mantey LR, Elgavish S, et al. Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy. Biochemistry 2006; 45(9): 2968-77.
[http://dx.doi.org/10.1021/bi0522504] [PMID: 16503651]
[38]
Kurochkina N, Yardeni T, Huizing M. Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria. Glycobiology 2010; 20(3): 322-37.
[http://dx.doi.org/10.1093/glycob/cwp176] [PMID: 19917666]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy